Wednesday, April 23, 2014. Last Update: Wed 11:00 AM EST

The Second Opinion

ocareshadow.jpg

Obamacare? I wasn’t aware…

A takeaway for reporters from the latest Kaiser poll numbers: don’t forget who the law is for

When it comes to summarizing the key findings of the latest Kaiser Health Tracking Poll, this Washington Post headline neatly... More

hasselbeck.jpg

Fox News, so confused?

Fox & Friends does nothing to clarify one woman’s confusing Obamacare trials, but still gets its message across

By now, we're accustomed to tales from the Obamacare trenches--good, bad, and ugly--spun in the media. There was Deborah Cavallaro,... More

seniorspay.jpg

Will seniors pay the price?

The hospital lobby’s agenda is clear—hit up Medicare beneficiaries, not hospitals, to pay for the “doctor fix”—and merits wider coverage

A telephone call with reporters on January 23 couldn't have been more explicit. The American Hospital Association, the big trade... More

healthID.jpg

Got health coverage? Prove it!

How widespread are proof-of-coverage problems? Fort Myers News-Press took an extra step to find out.

If insurance exchange shoppers thought their trials would necessarily end once they were--finally--able to log on and do the hard... More

obamacare.jpg

How to measure Obamacare success

It’s too soon to pass judgment. But reporters can keep the debate honest and focused on the law’s core goal

A woman I'll call Gina, a 58-year-old hairdresser and Manhattan resident, is one of more than 587,000 New Yorkers who... More

laurelrevisedhomepage.png

OC Register explodes Medicare myths

A laurel to the paper’s deep dive into Medicare Part D showing “profit trumps public interest”

As the Affordable Care Act tumbled along its rocky path to implementation, the media drew parallels between its disastrous... More

medicalbill.jpg

Wonkblog on the ACA cost-control feature that might make you change your doctor

Sarah Kliff explores why wonks love “narrow networks,” and why consumers might hate them

Score one for Sarah Kliff's Health Reform Watch column this week. Her Monday Q-and-A at WaPo's Wonkblog offered a clear,... More

ocareanecdote.jpg

Warning: This anecdote may be harmful to your story’s health

Six questions to ask before using an Obamacare tale

Healthcare-related media criticism doesn't often go viral, or even semi-viral, but the writer Maggie Mahar scored big earlier this month... More

laurelrevisedhomepage.png

A laurel for the Journal Sentinel

For five years, John Fauber has done standout reporting on the medical establishment’s unsavory business dealings

Those who say watchdog journalism is dead and gone are just plain wrong. And there's no better way to... More

DrugManufacturing.jpg

The new hepatitis C drug costs how much?!

NPR’s Richard Knox gets its right the second time around on high pharmaceutical prices

When the Food and Drug Administration in early December approved sofosbuvir, an important new drug to treat hepatitis C, most... More

medicalbill.jpg

The Great Cost Shift comes into focus

It’s time for the press to lead a conversation about who bears healthcare costs

As the tumultuous year of the Affordable Care Act comes to an end, one of the central storylines of health... More

SteveBrill.jpg

Brill is back, and other ACA shout-outs

Kudos to good work in Time and The New York Times

From time to time this space will offer a roundup of interesting, well-done, and useful stories about healthcare and health... More

docback.jpg

Exchange Watch: Missing doctors, missing coverage

In New York, insurance exchange shoppers (if not enough reporters) discover the lack of out-of-network benefits

At the tail end of October, when the media were hyper-fixated on the woes of HealthCare.gov and who knew what... More

medicalbill.jpg

Better late than never: the new insurance sticker shock story

The press discovers high cost sharing, but the story goes deeper

As coverage of the Affordable Care Act rolls along, the pesky subject of high out-of-pocket costs for plans purchased on... More

dollarsigns.jpg

Did the gee-whiz drug story make a comeback?

NPR’s piece on a new hepatitis C med fell short on costs, conflicts, and caveats

To hear NPR's piece last week about the FDA's then-imminent approval of a new drug to treat hepatitis C--sofosbuvir, approved... More

16 women whose digital startups deserve Vox-level plaudits - A look at the media entrepreneurs who aren’t grabbing headlines

Why was ‘Dasani’ shut out of the Pulitzers? - 5 problems with The New York Times’ ambitious, influential series on the life of one homeless Brooklyn girl

The AP downplays its Obamacare scoop - Repeal on deductible caps marks another step in The Great Cost Shift

The enduring pull of mag covers - Why do magazine cover images still hold so much cultural power in this decline-of-print era?

Michael Wolff’s digital media bloopers - The Newser founder trolls (other) digital-news companies


Why The Upshot?

“Perhaps most important, we want The Upshot to feel like a collaboration between journalists and readers”

Jonah Lehrer has a new blog

“I also hope this blog can be a small step towards regaining the trust of my readers”

The greatest threat to women

Louis CK is nonplussed at how ladies do it

  • If you like the magazine, get the rest of the year for just $19.95 (6 issues in all).
  • If not, simply write cancel on the bill and return it. You will owe nothing.

Who Owns What

The Business of Digital Journalism

A report from the Columbia University Graduate School of Journalism

Study Guides

Questions and exercises for journalism students.